MedPath

EPIGENOMICS, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

9

Active:0
Completed:7

Trial Phases

1 Phases

Early Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Early Phase 1
1 (100.0%)

Plasma-based Colorectal Cancer Screening Research & Development

Completed
Conditions
Colo-rectal Cancer
First Posted Date
2019-07-22
Last Posted Date
2021-02-02
Lead Sponsor
Epigenomics, Inc
Target Recruit Count
354
Registration Number
NCT04027790
Locations
🇺🇸

University of South Florida, Tampa, Florida, United States

🇺🇸

Springfield Clinic, Springfield, Illinois, United States

🇺🇸

Ochsner Clinic Foundation, New Orleans, Louisiana, United States

and more 2 locations

HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)

Completed
Conditions
Cirrhosis, Liver
Hepatic Cirrhosis
Hepatocellular Carcinoma
Liver Cancer
First Posted Date
2019-01-15
Last Posted Date
2020-01-30
Lead Sponsor
Epigenomics, Inc
Target Recruit Count
175
Registration Number
NCT03804593
Locations
🇺🇸

USC Keck Medical Center, Los Angeles, California, United States

🇺🇸

California Liver Research Institute, Pasadena, California, United States

Longitudinal Performance of Epi proColon

Conditions
Colorectal Neoplasms
Colorectal Cancer
First Posted Date
2017-07-14
Last Posted Date
2021-11-01
Lead Sponsor
Epigenomics, Inc
Target Recruit Count
4500
Registration Number
NCT03218423
Locations
🇺🇸

Veterans Affairs San Diego Healthcare System, San Diego, California, United States

🇺🇸

Beaumont Health System, Royal Oak, Michigan, United States

🇺🇸

Rutgers University Hospital, New Brunswick, New Jersey, United States

and more 3 locations

Adherence to Minimally Invasive Testing

Completed
Conditions
Colorectal Cancer
First Posted Date
2014-09-29
Last Posted Date
2015-06-30
Lead Sponsor
Epigenomics, Inc
Target Recruit Count
490
Registration Number
NCT02251782
Locations
🇺🇸

Kaiser Permanente Center for Health Research, Portland, Oregon, United States

🇺🇸

Geisinger Clinic, Danville, Pennsylvania, United States

Head to Head Study Epi proColon and FIT

Completed
Conditions
Colorectal Cancer
First Posted Date
2012-04-19
Last Posted Date
2015-08-04
Lead Sponsor
Epigenomics, Inc
Target Recruit Count
336
Registration Number
NCT01580540
Locations
🇺🇸

Achieve Clinical Research LLC, Birmingham, Alabama, United States

🇺🇸

Greater Arizona Gastroenterology Associates, Casa Grande, Arizona, United States

🇺🇸

Visions Clinical Research, Tucson, Arizona, United States

and more 67 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.